Showing 1721-1730 of 3135 results for "".
Health Care Reform, Reformed
https://practicaldermatology.com/topics/practice-management/health-care-reform-reformed/20839/The President-elect has vowed to dismantle the ACA—maybe. Practical Dermatology® investigates what TrumpCare may mean for dermatologists.Currents
https://practicaldermatology.com/topics/skin-cancer-photoprotection/currents/20991/Viewpoints: A New Roadmap in Eczema Care
https://practicaldermatology.com/topics/practice-management/viewpoints-a-new-roadmap-in-eczema-care/21144/New strategies in clinical care and advocacy will be essential in this emerging era of eczema management.Currents
https://practicaldermatology.com/topics/general-topics/currents/21175/New products and pharmacologic developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21235/News
https://practicaldermatology.com/topics/general-topics/news/21281/Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0909_05-php/22769/Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0509_05-php/22827/Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0409_05-php/22843/Valeant Business Update; Melanoma Drugs Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-valeant-business-update-melanoma-drugs-approved/18679/In this edition of DermWireTV from the editors of Practical Dermatology® magazine and DermWire.com, we take a look at Valeant's warning of disruption of dermatology business following its break from specialty pharmacy Philidor. Plus, an update on Melanoma Therapeutics, including approvals of Imlygic